Scythian Biosciences Inc. — Form D/A
Scythian Biosciences Inc. of CALGARY, A0, a company, filed a Form D amendment with the SEC on 2016-05-31. The offering totals $170K, of which $170K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-05-31
- Form: D/A
- Accession: 0001664115-16-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $170K
- Amount sold: $170K
- Investors: 12
- Date of first sale: 2015-07-20
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-264085
Issuer
- Name: Scythian Biosciences Inc.
- CIK: 0001664115
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2014
- Address: 1250-639 5TH AVENUE SW, CALGARY, A0, T2P 0M9
- Phone: (403) 613-7310
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Allan Cohen | Director | Ellicott City, MD |
| Mo Fazil | Director | Calgary, A0 |
| Jerome Gilbert | Director | Glen Rock, NJ |
| Jonathan Gilbert | Director | Delray Beach, FL |
| Harvey Lalach | Director | Kelowna, A1 |
| Michael Petter | Director | Calgary, A0 |
| David Schrader | Director | Calgary, A0 |
| Mo Fazil | Executive Officer | Calgary, A0 |
| Jonathan Gilbert | Executive Officer | Delray Beach, FL |
| Harvey Lalach | Executive Officer | Kelowna, A1 |
| David Schrader | Executive Officer | Calgary, A0 |
Other filings by this issuer (5)
More